Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36542644)

  • 21. High-Intensity Versus Low-Intensity Surveillance for Patients With Colorectal Adenomas: A Cost-Effectiveness Analysis.
    Meester RGS; Lansdorp-Vogelaar I; Winawer SJ; Zauber AG; Knudsen AB; Ladabaum U
    Ann Intern Med; 2019 Nov; 171(9):612-622. PubMed ID: 31546257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluating health benefits and cost-effectiveness of a mass-media campaign for improving participation in the National Bowel Cancer Screening Program in Australia.
    Worthington J; Feletto E; Lew JB; Broun K; Durkin S; Wakefield M; Grogan P; Harper T; Canfell K
    Public Health; 2020 Feb; 179():90-99. PubMed ID: 31760206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential for prevention: a cohort study of colonoscopies and removal of adenomas in a FIT-based colorectal cancer screening programme.
    Larsen MB; Njor SH; Jensen TM; Ingeholm P; Andersen B
    Scand J Gastroenterol; 2019 Aug; 54(8):1008-1014. PubMed ID: 31397598
    [No Abstract]   [Full Text] [Related]  

  • 24. Socioeconomic and demographic inequalities in stage at diagnosis and survival among colorectal cancer patients: evidence from a Swiss population-based study.
    Feller A; Schmidlin K; Bordoni A; Bouchardy C; Bulliard JL; Camey B; Konzelmann I; Maspoli M; Wanner M; Zwahlen M; Clough-Gorr KM;
    Cancer Med; 2018 Apr; 7(4):1498-1510. PubMed ID: 29479854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Time Trends in Colorectal Cancer Incidence Rates by Income and Age at Diagnosis in Canada From 1992 to 2016.
    Decker KM; Lambert P; Bravo J; Demers A; Singh H
    JAMA Netw Open; 2021 Jul; 4(7):e2117556. PubMed ID: 34279645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Faecal occult blood testing (FOBT)-based colorectal cancer screening trends and predictors of non-use: findings from the South Australian setting and implications for increasing FOBT uptake.
    Todorov K; Wilson C; Sharplin G; Corsini N
    Aust Health Rev; 2018 Feb; 42(1):45-52. PubMed ID: 28248632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Geographic variation in compliance with Australian colorectal cancer screening programs: the role of attitudinal and cognitive traits.
    Goodwin BC; March S; Ireland M; Crawford Williams F; Manksi D; Ford M; Dunn J
    Rural Remote Health; 2019 Jul; 19(3):4957. PubMed ID: 31340653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What can We Learn From High-Performing Screening Programs to Increase Bowel Cancer Screening Participation in Australia?
    Flander L; Dekker E; Andersen B; Larsen MB; Steele RJ; Malila N; Sarkeala T; van der Vlugt M; de Klerk C; Knottnerus B; Bertels L; Woudstra A; Spaander MCW; Fransen M; Heinavaara S; Dillon M; Ait Ouakrim D; Jenkins M
    Cancer Control; 2022; 29():10732748221121383. PubMed ID: 35969473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sociodemographic disparities in survival from colorectal cancer in South Australia: a population-wide data linkage study.
    Beckmann KR; Bennett A; Young GP; Cole SR; Joshi R; Adams J; Singhal N; Karapetis C; Wattchow D; Roder D
    BMC Health Serv Res; 2016 Jan; 16():24. PubMed ID: 26792195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colorectal cancer surveillance by colonoscopy in a prospective, population-based long-term Swiss screening study - outcomes, adherence, and costs.
    Zgraggen A; Stoffel ST; Barbier MC; Marbet UA
    Z Gastroenterol; 2022 May; 60(5):761-778. PubMed ID: 35545112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Equity of colorectal cancer screening: cross-sectional analysis of National Bowel Cancer Screening Program data for South Australia.
    Ward PR; Javanparast S; Matt MA; Martini A; Tsourtos G; Cole S; Gill T; Aylward P; Baratiny G; Jiwa M; Misan G; Wilson C; Young G
    Aust N Z J Public Health; 2011 Feb; 35(1):61-5. PubMed ID: 21299702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Socioeconomic Inequalities in Colorectal Cancer Screening in Korea, 2005-2015: After the Introduction of the National Cancer Screening Program.
    Mai TTX; Lee YY; Suh M; Choi E; Lee EY; Ki M; Cho H; Park B; Jun JK; Kim Y; Oh JK; Choi KS
    Yonsei Med J; 2018 Nov; 59(9):1034-1040. PubMed ID: 30328317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adenoma detection rate metrics in colorectal cancer surveillance colonoscopy.
    Tjaden JM; Hause JA; Berger D; Duveneck SK; Jakate SM; Orkin BA; Hubbard EL; Melson JE
    Surg Endosc; 2018 Jul; 32(7):3108-3113. PubMed ID: 29340817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness of family history-based colorectal cancer screening in Australia.
    Ouakrim DA; Boussioutas A; Lockett T; Hopper JL; Jenkins MA
    BMC Cancer; 2014 Apr; 14():261. PubMed ID: 24735237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of colorectal cancer screening participation in remote northern Canada: A retrospective cohort study.
    Smith HA; Scarffe AD; Brunet N; Champion C; Kandola K; Tessier A; Boushey R; Kuziemsky C
    World J Gastroenterol; 2020 Dec; 26(48):7652-7663. PubMed ID: 33505142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Adenoma Detection Rate and Adenoma Characteristics With Colorectal Cancer Mortality After Screening Colonoscopy.
    Waldmann E; Kammerlander AA; Gessl I; Penz D; Majcher B; Hinterberger A; Bretthauer M; Trauner MH; Ferlitsch M
    Clin Gastroenterol Hepatol; 2021 Sep; 19(9):1890-1898. PubMed ID: 33878471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes and cost evaluation of the first two rounds of a colorectal cancer screening program based on immunochemical fecal occult blood test in northern Italy.
    Parente F; Boemo C; Ardizzoia A; Costa M; Carzaniga P; Ilardo A; Moretti R; Cremaschini M; Parente EM; Pirola ME
    Endoscopy; 2013; 45(1):27-34. PubMed ID: 23254404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative effectiveness of screening strategies for colorectal cancer.
    Barzi A; Lenz HJ; Quinn DI; Sadeghi S
    Cancer; 2017 May; 123(9):1516-1527. PubMed ID: 28117881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colorectal cancer screening for average-risk North Americans: an economic evaluation.
    Heitman SJ; Hilsden RJ; Au F; Dowden S; Manns BJ
    PLoS Med; 2010 Nov; 7(11):e1000370. PubMed ID: 21124887
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.